{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Haloperidol&page=2", "query": { "intervention": "Haloperidol", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Haloperidol&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-04T10:19:35.400Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02625181", "title": "Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postoperative Nausea and Vomiting" ], "interventions": [ { "name": "Automated recommendation at the start of the case", "type": "PROCEDURE" }, { "name": "Automated notification at the start of surgery", "type": "PROCEDURE" }, { "name": "Preoperative recommendations: by email", "type": "PROCEDURE" }, { "name": "Automated notification at the end of surgery", "type": "PROCEDURE" }, { "name": "Anesthesia Information Management System (AIMS)", "type": "DEVICE" }, { "name": "Perioperative Data Warehouse (PDW)", "type": "DEVICE" }, { "name": "General anesthesia", "type": "PROCEDURE" }, { "name": "Elective surgery", "type": "PROCEDURE" }, { "name": "Propofol", "type": "DRUG" }, { "name": "Sevoflurane", "type": "DRUG" }, { "name": "Isoflurane", "type": "DRUG" }, { "name": "Desflurane", "type": "DRUG" }, { "name": "Scopolamine", "type": "DRUG" }, { "name": "Droperidol", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Promethazine", "type": "DRUG" }, { "name": "Meclizine", "type": "DRUG" }, { "name": "Aprepitant", "type": "DRUG" }, { "name": "Metoclopramide", "type": "DRUG" }, { "name": "Fentanyl", "type": "DRUG" }, { "name": "Sufentanil", "type": "DRUG" }, { "name": "Alfentanil", "type": "DRUG" }, { "name": "Remifentanil", "type": "DRUG" }, { "name": "Morphine", "type": "DRUG" }, { "name": "Meperidine", "type": "DRUG" }, { "name": "Hydromorphone", "type": "DRUG" }, { "name": "Methadone", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" }, { "name": "Oxymorphone", "type": "DRUG" }, { "name": "Hydrocodone", "type": "DRUG" }, { "name": "Ketamine", "type": "DRUG" }, { "name": "Ondansetron", "type": "DRUG" }, { "name": "Granisetron", "type": "DRUG" }, { "name": "Dolasetron mesylate", "type": "DRUG" }, { "name": "Palonosetron", "type": "DRUG" }, { "name": "Tropisetron", "type": "DRUG" }, { "name": "Ramosetron", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DEVICE", "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27034, "start_date": "2016-07", "completion_date": "2017-11-30", "has_results": true, "last_update_posted_date": "2019-03-07", "last_synced_at": "2026-09-04T10:19:35.400Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02625181" }, { "nct_id": "NCT02057549", "title": "Haloperidol vs Conventional Therapy for Gastroparesis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Gastroparesis" ], "interventions": [ { "name": "Haloperidol", "type": "DRUG" }, { "name": "Conventional Therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 36, "start_date": "2012-11", "completion_date": "2016-11", "has_results": true, "last_update_posted_date": "2017-08-17", "last_synced_at": "2026-09-04T10:19:35.400Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02057549" }, { "nct_id": "NCT04715230", "title": "Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Methamphetamine Intoxication (Disorder)" ], "interventions": [ { "name": "IXT-m200", "type": "BIOLOGICAL" }, { "name": "Lorazepam", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "InterveXion Therapeutics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 20, "start_date": "2021-06-30", "completion_date": "2022-11-14", "has_results": true, "last_update_posted_date": "2023-11-18", "last_synced_at": "2026-09-04T10:19:35.400Z", "location_count": 4, "location_summary": "Little Rock, Arkansas • Albuquerque, New Mexico • Everett, Washington + 1 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Albuquerque", "state": "New Mexico" }, { "city": "Everett", "state": "Washington" }, { "city": "Spokane", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04715230" }, { "nct_id": "NCT00340379", "title": "Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Affective Disorders" ], "interventions": [ { "name": "Ziprasidone", "type": "DRUG" }, { "name": "Sertraline", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 72, "start_date": "2003-04", "completion_date": "2005-08", "has_results": true, "last_update_posted_date": "2014-08-19", "last_synced_at": "2026-09-04T10:19:35.400Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00340379" }, { "nct_id": "NCT02085447", "title": "A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Psychotic Disorders", "Schizophrenia", "Schizoaffective Disorder", "Medication Adherence", "Medication Non-Adherence" ], "interventions": [ { "name": "CAE-L", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University Hospitals Cleveland Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2014-05", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2019-12-09", "last_synced_at": "2026-09-04T10:19:35.400Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02085447" }, { "nct_id": "NCT01211522", "title": "The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Delirium", "Impaired Cognition", "Long Term Psychologic Disorders" ], "interventions": [ { "name": "Haloperidol", "type": "DRUG" }, { "name": "Ziprasidone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 566, "start_date": "2011-12-14", "completion_date": "2018-07-19", "has_results": true, "last_update_posted_date": "2019-11-18", "last_synced_at": "2026-09-04T10:19:35.400Z", "location_count": 16, "location_summary": "Denver, Colorado • New Haven, Connecticut • Indianapolis, Indiana + 12 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01211522" }, { "nct_id": "NCT00203775", "title": "Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Psychosis", "Aggression" ], "interventions": [ { "name": "risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Connecticut", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2002-07", "completion_date": "2004-04", "has_results": false, "last_update_posted_date": "2006-10-13", "last_synced_at": "2026-09-04T10:19:35.400Z", "location_count": 1, "location_summary": "Farmington, Connecticut", "locations": [ { "city": "Farmington", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00203775" }, { "nct_id": "NCT01949662", "title": "Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Advanced Cancers" ], "interventions": [ { "name": "Lorazepam", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Haloperidol decanoate", "type": "DRUG" }, { "name": "Questionnaires", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 93, "start_date": "2014-01", "completion_date": "2028-01-01", "has_results": true, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-09-04T10:19:35.400Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01949662" }, { "nct_id": "NCT00169091", "title": "Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Clozapine", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Harvard Medical School (HMS and HSDM)", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 32, "start_date": "1996-03", "completion_date": "2003-10", "has_results": false, "last_update_posted_date": "2015-04-07", "last_synced_at": "2026-09-04T10:19:35.400Z", "location_count": 1, "location_summary": "Jamaica Plain, Massachusetts", "locations": [ { "city": "Jamaica Plain", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00169091" }, { "nct_id": "NCT02343575", "title": "Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hyperactive Delirium", "Mixed Delirium" ], "interventions": [ { "name": "Valproic Acid", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2015-01", "completion_date": "2018-01", "has_results": true, "last_update_posted_date": "2019-06-26", "last_synced_at": "2026-09-04T10:19:35.400Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02343575" } ] }